CoChat

Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes

Open access
Sigurdson, Alice J, Hauptmann, Michael, Chatterjee, Nilanjan, Alexander, Bruce H, Doody, Michele Morin, Rutter, Joni L, Struewing, Jeffery P · 2004 · BMC Cancer
Cited by 92

The DOI matches its Crossref record.

Abstract

BACKGROUND: Subtle functional deficiencies in highly conserved DNA repair or growth regulatory processes resulting from polymorphic variation may increase genetic susceptibility to breast cancer. Polymorphisms in DNA repair genes can impact protein function leading to genomic instability facilitated by growth stimulation and increased cancer risk. Thus, 19 single nucleotide polymorphisms (SNPs) in eight genes involved in base excision repair (XRCC1, APEX, POLD1), BRCA1 protein interaction (BRIP1, ZNF350, BRCA2), and growth regulation (TGFss1, IGFBP3) were evaluated. METHODS: Genomic DNA samples were used in Taqman 5'-nuclease assays for most SNPs. Breast cancer risk to ages 50 and 70 were estimated using the kin-cohort method in which genotypes of relatives are inferred based on the known genotype of the index subject and Mendelian inheritance patterns. Family cancer history data was collected from a series of genotyped breast cancer cases (N = 748) identified within a cohort of female US radiologic technologists. Among 2,430 female first-degree relatives of cases, 190 breast cancers were reported. RESULTS: Genotypes associated with increased risk were: XRCC1 R194W (WW and RW vs. RR, cumulative risk up to age 70, risk ratio (RR) = 2.3; 95% CI 1.3-3.8); XRCC1 R399Q (QQ vs. RR, cumulative risk up to age 70, RR = 1.9; 1.1-3.9); and BRIP1 (or BACH1) P919S (SS vs. PP, cumulative risk up to age 50, RR = 6.9; 1.6-29.3). The risk for those heterozygous for BRCA2 N372H and APEX D148E were significantly lower than risks for homozygotes of either allele, and these were the only two results that remained significant after adjusting for multiple comparisons. No associations with breast cancer were observed for: APEX Q51H; XRCC1 R280H; IGFPB3 -202A>C; TGFss1 L10P, P25R, and T263I; BRCA2 N289H and T1915M; BRIP1 -64A>C; and ZNF350 (or ZBRK1) 1845C>T, L66P, R501S, and S472P. CONCLUSION: Some variants in genes within the base-excision repair pathway (XRCC1) and BRCA1 interacting proteins (BRIP1) may play a role as low penetrance breast cancer risk alleles. Previous association studies of breast cancer and BRCA2 N372H and functional observations for APEX D148E ran counter to our findings of decreased risks. Due to the many comparisons, cautious interpretation and replication of these relationships are warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2407-4-9

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 43

  1. Mohrenweiser HW, Jones IM: Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?. Mutat Res. 1998, 400: 15-24. 10.1016/S0027-5107(98)00059-1. · DOI · Paper page
  2. Roberts SA, Spreadborough AR, Bulman B, Barber JBP, Evans DGR, Scott D: Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?. Am J Hum Genet. 1999, 65: 784-794. 10.1086/302544. · DOI · Paper page
  3. Teare MD, Wallace SA, Harris M, Howell A, Birch JM: Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer. 1994, 70: 102-111. · DOI
  4. Anglian Breast Cancer Study Group: Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases. Br J Cancer. 2000, 83: 1301-1308. 10.1054/bjoc.2000.1407. · DOI · Paper page
  5. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999, 91: 943-949. 10.1093/jnci/91.11.943. · DOI · Paper page
  6. Antoniou AC, Pharoah PDP, McMullen G, Day NE, Ponder BAJ, Easton DF: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet Epidemiol. 2002, 21: 1-18. 10.1002/gepi.1014. · DOI · Paper page
  7. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WTA, Oosterwijk JC, Kleibeuker JH, Schaapveld M, de Vries EGE: Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet. 2002, 39: 225-242. 10.1136/jmg.39.4.225. · DOI · Paper page
  8. Nathanson KL, Wooster R, Weber BL: Breast cancer genetics: what we know and what we need. Nature Medicine. 2001, 7: 552-556. 10.1038/87876. · DOI · Paper page
  9. Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BAJ: Polygenic susceptibility to breast cancer and implications for prevention. Nature Genet. 2002, 31: 33-36. 10.1038/ng853. · DOI · Paper page
  10. Mohrenweiser HW, Xi T, Vazquez-Matias J, Jones IM: Identification of 127 Amino Acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1054-1064.
  11. Mohrenweiser HW, Wilson DM, Jones IM: Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res. 2003, 526: 93-125. 10.1016/S0027-5107(03)00049-6. · DOI · Paper page
  12. Easton DF: How many more breast cancer predisposition genes are there?. Breast Cancer Res. 1999, 1: 14-17. 10.1186/bcr6. · DOI · Paper page
  13. Wacholder S, Hartge P, Struewing JP, Pee D, McAdams M, Brody L, Tucker M: The kin-cohort study for estimating penetrance. Am J Epidemiol. 1998, 148: 623-630. · DOI · Paper page
  14. Gail MH, Pee D, Carroll R: Kin-cohort designs for gene characterization. J Natl Cancer Inst Monogr. 1999, 26: 55-60. · DOI
  15. Chatterjee N, Wacholder S: A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics. 2001, 57: 245-252. · DOI · Paper page
  16. Saunders CL, Begg CB: Kin-cohort evaluation of relative risks of genetic variants. Genet Epidemiol. 2003, 24: 220-229. 10.1002/gepi.10235. · doi:10.1002/gepi.10235
  17. Rutter JL, Chatterjee N, Wacholder S, Struewing JP: The HER2 I655V polymorphism and breast cancer risk in Ashkenazim. Epidemiology. 2003, 14: 694-700. · DOI
  18. Hochberg Y: A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988, 75: 800-80. · DOI · Paper page
  19. Benjamini Y, Liu W: A distribution-free multiple test procedure that controls the false discovery rate. Department of Statistics and O.R., Tel Aviv University. Technical report RP-SOR-99-3. Tel Aviv. 1999
  20. Thompson LH, West MG: XRCC1 keeps DNA from getting stranded (review). Mutation Res. 2000, 459: 1-18. 10.1016/S0921-8777(99)00058-0. · DOI · Paper page
  21. Shen MR, Jones IM, Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA genes in healthy humans. Cancer Res. 1998, 58: 604-608.
  22. Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1513-1530.
  23. Duell EJ, Millikan , Pittman GS, Winkel S, Lunn RM, Tse C-KJ, Eaton A, Mohrenweiser HW, Newman B, Bell DA: Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev. 2001, 10: 217-222.
  24. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW, Hu JJ: Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett. 2003, 190: 183-190. 10.1016/S0304-3835(02)00595-5. · DOI · Paper page
  25. Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, Lohman K, Case LD, Xu J, Mohrenweiser HW, Hu JJ: DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1200-1204.
  26. Kim SU, Park SK, Yoo KY, Yoon KS, Choi JY, Seo JS, Park WY, Kim JH, Noh DY, Ahn SH, Choe KJ, Strickland PT, Hirvonen A, Kang D: XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics. 2002, 12: 335-338. 10.1097/00008571-200206000-00010. · doi:10.1097/00008571-200206000-00010
  27. Moullan N, Cox DG, Angele S, Romestaing P, Gerard J-P, Hall J: Polymorphisms in the DNA repair genes XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1200-1204.
  28. Shu X-O, Cai Q, Gao Y-T, Wen W, Jin F, Zheng W: A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1462-1467.
  29. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA: XRCC1 polymorphisms: Effects on Aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999, 59: 2557-2561.
  30. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD: Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001, 22: 917-922. 10.1093/carcin/22.6.917. · doi:10.1093/carcin/22.6.917
  31. Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, Masala G, Berrino F, Panico S, Tumino R, Vineis P, Palli D: Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev. 2003, 12: 674-647.
  32. Taylor RM, Thistlethwaite A, Caldecott KW: Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol. 2002, 22: 2556-2563. 10.1128/MCB.22.8.2556-2563.2002. · DOI · Paper page
  33. Wilson DM, Thompson LH: Life without DNA repair. Proc Natl Acad Sci. 1997, 94: 12754-12757. 10.1073/pnas.94.24.12754. · DOI · Paper page
  34. Rutter JL, Smith A, Davila M, Sigurdson AJ, Doody MM, Tucker MA, Greene M, Struewing JP: Mutational analysis of BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Hum Mutat. 2003, 22: 121-128. 10.1002/humu.10238. · DOI · Paper page
  35. Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN: Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer. 2003, 107: 60-64. 10.1002/ijc.11358. · DOI
  36. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS: Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology. 1998, 9: 570-573. · DOI · Paper page
  37. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirer O: Polymorphisms of the transforming growth factor b1 gene in relation to myocardial infarction and blood pressure. Hypertension. 1996, 28: 881-887. · DOI · Paper page
  38. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS: Association between the T29-->C polymorphism in the transforming growth factor beta 1 gene and breast cancer among elderly white women: the study of osteoporotic fractures. JAMA. 2001, 285: 2859-2863. 10.1001/jama.285.22.2859. · doi:10.1001/jama.285.22.2859
  39. Dunning AM, Ellis Pd, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalf JC: A transforming growth factor ß1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res. 2003, 63: 2610-2615.
  40. Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA: A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet. 2000, 26: 362-364. 10.1038/81691. · DOI
  41. Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G: The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev. 2002, 11: 413-416.
  42. Auranen A, Spurdle AB, Chen X, Lipscombe J, Purdie DM, Hopper JL, Green A, Healey CS, Redman K, Dunning AM, Pharoah PD, Easton DF, Ponder BA, Chenevix-Trench G, Novik KL: BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk. Int J Cancer. 2003, 103: 427-430. 10.1002/ijc.10814. · DOI
  43. Airewele G, Adatto P, Cunningham J, Mastromarino C, Spencer C, Sharp M, Sigurdson A, Bondy M: Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst. 1998, 90: 543-544. 10.1093/jnci/90.7.543. · doi:10.1093/jnci/90.7.543

Cited by

See all 92

Metadata

Authors
Sigurdson, A. J., Hauptmann, M., Chatterjee, N., Alexander, B. H., Doody, M. M., Rutter, J. L., & Struewing, J. P.
Venue
BMC Cancer
Published
2004-03-12
Volume
4
Issue
1
Pages
9-9
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2131347613
Cited by
92
References
0
FWCI
4.71
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. https://app.cochat.ai/papers/10.1186/1471-2407-4-9
The paper
Sigurdson, A. J., Hauptmann, M., Chatterjee, N., Alexander, B. H., Doody, M. M., Rutter, J. L., & Struewing, J. P. (2004). Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer. https://doi.org/10.1186/1471-2407-4-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.